Stanford University
Peter Tass, MD, PhD
The purpose of our study is to evaluate Vibrotactile Coordinated Reset stimulation (vCR) and its effects on refractory post-surgery PD. vCR will be administered with a device called the Stanford Glove. vCR is expected to provide patients with a non-invasive alternative to the most widely used treatments such as levodopa and or deep brain stimulation. Patients will be followed for two years.
Parkinson Disease
Vibrotactile Coordinated Reset (vCR)
Not Applicable
Study Type : | Interventional |
Estimated Enrollment : | 10 participants |
Masking : | None (Open Label) |
Primary Purpose : | Treatment |
Official Title : | Vibrotactile Coordinated Reset for the Treatment of Post Surgery Refractory Parkinson's Disease Patients |
Actual Study Start Date : | August 20, 2024 |
Estimated Primary Completion Date : | November 21, 2025 |
Estimated Study Completion Date : | November 21, 2025 |
Arm | Intervention/treatment |
---|---|
Experimental: Vibrotactile Coordinated Reset (vCR) Vibrotactile Coordinated Reset delivers vibratory stimulation to the fingertips of each hand. A specific pattern of vibration to each fingertip is delivered which theoretically disrupts abnormal synchrony in the brain. |
Device: Vibrotactile Coordinated Reset (vCR) |
Ages Eligible for Study: | 35 Years to 92 Years |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
Stanford University
Stanford, California, United States, 94305